Alpha-fetoprotein peptides and uses thereof

Details for Australian Patent Application No. 2001268133 (hide)

Owner CLF Medical Technology Acceleration Program, Inc.

Inventors Mesfin, Fassil B.; Andersen, Thomas T.; Jacobson, Herbert I.; Bennett, James A.

Agent Cullen & Co

Pub. Number AU-B-2001268133

PCT Pub. Number WO2003/007978

Filing date 2 June 2001

Wipo publication date 3 March 2003

Acceptance publication date 15 May 2008

International Classifications

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 15/06 (2006.01) Drugs for genital or sexual disorders

A61P 15/18 (2006.01) Drugs for genital or sexual disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/64 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2001268133

15 May 2008 Application Accepted

  Published as AU-B-2001268133

11 September 2008 Standard Patent Sealed

6 January 2011 Assignment Registered

  CLF Medical Technology Acceleration Program, Inc. The patent has been assigned to Albany Medical College

3 March 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 11 Jan 2011. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000 2003

7 July 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 11 Jan 2011 2004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001268134

2001268132-Benzamide ligands for the thyroid receptor